The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital in Boston. “Over the last…  read on >  read on >

WEDNESDAY, Nov. 17, 2021 (American Heart Association News) — Family-based programs to encourage healthier eating and physical activity have long been regarded as an effective way to put children diagnosed as overweight or with obesity on a path to a better future. But new research suggests an added dividend: Parents of those children can benefit…  read on >  read on >

Grandmothers can have a strong bond with the little children in their families — and the connection even shows up on brain scans, researchers say. The investigators embarked on a unique study, looking at the brains of older women — not for signs of dysfunction, as with dementia, but to study their connections with their…  read on >  read on >

WEDNESDAY, Nov. 17, 2021 (HealthDay News) – When young people are allowed to give their own consent for human papillomavirus (HPV) vaccines, vaccination rates are higher, new research shows. The new study suggests that allowing teens to consent without parental involvement could be an important strategy for boosting HPV vaccination rates. This consent is already…  read on >  read on >

Lung cancer survival rates in the United States continue to rise, but certain racial groups are still hit hard by the disease, the American Lung Association reports. Its fourth annual “State of Lung Cancer” report shows that the average five-year survival rate increased from 14.5% to nearly 24%, but it remains at 20% for people…  read on >  read on >